NeuroBo Pharmaceuticals Depreciation & Amortization 2011-2026 | NRBO

Annual Depreciation & Amortization NeuroBo Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19 K	20 K	6 K	20 K	48 K	46 K	17 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48 K	6 K	25.1 K

Quarterly Depreciation & Amortization NeuroBo Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5 K	5 K	4 K	-	5 K	6 K	4 K	-	1 K	-	1 K	-	19 K	17 K	12 K	-	36 K	24 K	12 K	-	12 K	12 K	11 K	-	5 K	1 K	1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36 K	1 K	9.65 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.36	-2.52 %	$ 362 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	2.99 M	$ 20.25	-0.54 %	$ 2.83 B	France
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.6	-2.26 %	$ 16.3 M	USA
Fate Therapeutics FATE	12.9 M	$ 1.14	-4.2 %	$ 135 M	USA
Forte Biosciences FBRX	64 K	$ 26.44	-	$ 342 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Amicus Therapeutics FOLD	7.46 M	$ 14.46	0.03 %	$ 4.46 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Fulcrum Therapeutics FULC	1.39 M	$ 7.57	-3.32 %	$ 480 K	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Galectin Therapeutics GALT	1 K	$ 2.28	-11.13 %	$ 146 M	USA
Gilead Sciences GILD	370 M	$ 138.34	-1.28 %	$ 172 B	USA
Galmed Pharmaceuticals Ltd. GLMD	42 K	$ 0.54	4.28 %	$ 503 K	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Gossamer Bio GOSS	24 K	$ 0.32	-7.11 %	$ 73.1 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.62	-3.29 %	$ 190 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
GT Biopharma GTBP	4 K	$ 0.41	-8.56 %	$ 2.26 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 316.69	-4.13 %	$ 41.5 B	USA
Halozyme Therapeutics HALO	11.4 M	$ 63.72	1.01 %	$ 7.64 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Harmony Biosciences Holdings HRMY	23.8 M	$ 27.53	-0.67 %	$ 1.58 B	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA